Use of serum is authorized for early treatment of COVID-19

January 11, 2021

Luis Ostrosky, MD, spoke to Telemundo Houston Channel 47 about Bamlanivimab, a monoclonal antibody treatment for COVID-19 that recently received emergency use authorization from the U.S. Food and Drug Administration. The story was also shared online.

December 17, 2020

Share content